New hope for tough cancers: EVOLVE104 trial begins
Disease control
Recruiting now
This early-phase study tests a new drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell cancers (lung, esophagus, skin, and others) that have not responded to standard treatments. About 160 participants will receive the drug to see if it …
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated May 07, 2026 18:42 UTC